Pleiotropic effects of statins: New evidences

dc.contributor.authorOkyay, Kaan
dc.contributor.pubmedID34623295en_US
dc.date.accessioned2022-08-08T08:22:45Z
dc.date.available2022-08-08T08:22:45Z
dc.date.issued2021
dc.identifier.endpage535en_US
dc.identifier.issn1016-5169en_US
dc.identifier.issue7en_US
dc.identifier.scopus2-s2.0-85118285991en_US
dc.identifier.startpage533en_US
dc.identifier.urihttp://hdl.handle.net/11727/7258
dc.identifier.volume49en_US
dc.identifier.wos000707718900003en_US
dc.language.isoengen_US
dc.relation.isversionof10.5543/tkda.2021.21211en_US
dc.relation.journalTURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectATRIAL-FIBRILLATIONen_US
dc.subjectCORONARYen_US
dc.subjectROSUVASTATINen_US
dc.subjectATORVASTATINen_US
dc.subjectPRETREATMENTen_US
dc.subjectMETAANALYSISen_US
dc.subjectREDUCTIONen_US
dc.subjectSURGERYen_US
dc.subjectTHERAPYen_US
dc.titlePleiotropic effects of statins: New evidencesen_US
dc.typeeditorialen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: